Skip to content

Research on the effectiveness of the My Asa Program

Research on the effectiveness of the My Asa Program - Research on the effectiveness of the My Asa Program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056650
Enrollment
80
Registered
2025-01-07
Start date
2025-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Subjects will follow the designated My Asa program (diet, water intake, exercise, and lifestyle guidance) for 60 days and take supplements assigned to Group I or Group II. Group I: Each morning, on

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor
HEM Pharma Inc
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who have been fully informed of the purpose and content of this research, have the capacity to consent, fully understand, and freely and voluntarily volunteer to participate in this research, and agree to participate in the study. 2.Persons who are Japanese men and women aged 18 to under 65 at the time of obtaining consent.

Exclusion criteria

Exclusion criteria: 1.Persons who are receiving medication for a chronic disease or have a history of a serious disease. 2.Persons who are allergic to any of the foods in the study. 3.Persons who are taking antibiotics or undergoing colonoscopy in 2 weeks prior to and during the study. 4.Persons who are taking supplements or protein supplements on a regular basis. 5.Persons who are regularly taking medicines or health foods (food for specified health use, food with functional claims, food with nutrient function claims), etc. that may affect the intestinal environment. 6.Persons who have participated in other studies during one month prior to the start of this study, or who plan to participate in other studies after consenting to this study. 7.Persons who are judged to be ineligible by the supervising doctor or the principal investigator. 8.Persons who are lactating, pregnant, or planning or wishing to become pregnant during the study period.

Design outcomes

Primary

MeasureTime frame
Fecal microbiome

Secondary

MeasureTime frame
Fecal metabolome analysis Questionnaire on gut health Questionnaire on lifestyle

Countries

Japan

Contacts

Public ContactHaruna Yamashita

Healthcare Systems Co., Ltd. Clinical Research Department

Yamashita.haruna@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026